|
Polycystic Ovarian Syndrome (PCOS) is a common cause of infertility. Patients with
PCOS often have insulin resistance, which means that your pancreas is producing a large
amount of insulin to maintain a normal glucose level. This is called hyperinsulinemia.
Hyperinsulinemia leads to increased levels of androgens in the ovaries. This may directly
interfere with ovulation. Metformin is an oral antihyperglycemic agent and has been
shown to improve the body’s use of insulin, therefore, decreasing androgen levels and
restoring normal ovulatory function.
PRIOR TO TREATMENT:
You will need the following labs before starting metformin:
-
FASTING BLOOD SUGAR
-
INSULIN LEVEL
-
BUN, CREATININE
-
DHEAS, TESTOSTERONE, 17-OHP
DURING TREATMENT:
It is very important to maintain a proper diet. Weight loss has been demonstrated to
decrease androgen levels as well as achieve increased insulin sensitivity. A daily
exercise routine is essential to your health, especially during therapy.
Avoid excessive alcohol intake while taking metformin. Alcohol increases your risk
of lactic acidosis. Lactic acidosis is caused by a build-up of lactic acid in the
blood. This condition is rare and occurs mostly in people whose kidneys are not
working normally.
HOW TO TAKE METFORMIN:
Metformin comes in 500-mg tablets and is started at once daily for one week, then
increased to twice daily for the second week, and then finally three times daily. If
you miss a dose, take it as soon as you remember. If it is near the time of the next
dose, skip the missed dose and resume your usual dosing schedule. Do not “double up”.
SIDE EFFECTS:
Common side effects are nausea, vomiting, diarrhea, loss of appetite, stomach fullness,
constipation, and heartburn.
GOAL OF THERAPY:
To decrease insulin resistance and androgen levels, establishing the return of normal
ovulatory cycles and decreasing the long-term health problems, as well as to eradicate
unwanted hirsutism (hair growth), acne, and obesity.
PREGNANCY:
Discontinue metformin with positive pregnancy test. Metformin is pregnancy category “B”
indicating that there are no apparent fetal risks based on animal reproductive studies
nor any risks associated with use of the drug during the late trimesters of pregnancy.
If you are a known diabetic, your obstetrician may continue the drug or switch you over
to insulin.
Our Mission Statement "...Exceeding patient expectations..."
|